����ֱ��

Methamphetamine is more common in places where it’s illegal to sell liquor.

First Lady Jane Beshear, along with representatives from the Kentucky Cancer Program, the University of Louisville’s James Graham Brown Cancer Center and KentuckyOne Health, is launching a new Horses and Hope campaign to raise $1 million for a mobile unit to provide free or significantly reduced cost cancer screenings to underserved populations across Kentucky.

The Wendy L. Novak Diabetes Care Center of the University of Louisville Pediatric Endocrinology Division in the Department of Pediatrics has been named an accredited program with the American Association of Diabetes Educators (AADE).

More than 50 UofL students, alumni and fans performed some pre-bowl game service - community service - in Charlotte, N.C. the morning of the Belk Bowl, Dec. 30, 2014.

Vladimir Putin. Medieval manuscripts. Turkish politics. Art markets. Researchers who study those diverse topics will share their views with the public through a University of Louisville luncheon lecture series this spring.

Morris Animal Foundation has awarded a three-year, $155,000 grant to a team of Kentucky and Danish researchers to build a new reference genome sequence for the domestic horse. The sequence will be a much needed tool for animal researchers worldwide and the equine industry in particular because it will significantly improve the ability to understand the role of genetics in animal health and well being.

Researchers at the University of Louisville’s James Graham Brown Cancer Center have identified for the first time mutations that destabilize a DNA structure that turns a gene off. These mutations occur at four specific sites in what is known as the “hTERT promoter” in more than 75 percent of glioblastomas and melanomas.

Research to Prevent Blindness (RPB) has awarded a grant of $115,000 to the University of Louisville Department of Ophthalmology and Visual Sciences, bringing the total of grant funding awarded over the past 50 years from RPB to $3,959,800. The latest grant was awarded Dec. 3.

Dr. Gregory Postel, who had been serving as interim CEO of University of Louisville Physicians, has been named permanent CEO of the organization. Postel was chosen to lead the organization long term by its board.

Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, announced that the University of Texas MD Anderson Cancer Center in Houston and the University of Texas Health Science Center at San Antonio have been added as human clinical trial sites for PFK-158, a first-in-man/first-in-class inhibitor of PFKFB3, an enzyme that controls glycolysis and that is overexpressed in most hematological and solid tumors. The two new clinical trial sites are expected to begin enrolling patients Jan. 1, 2015.